Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sushi, nidogen and EGF-like domains 1 (SNED1) is a modular extracellular matrix glycoprotein characterized by a combination of NIDO, sushi (CCP), follistatin, EGF-like, calcium-binding EGF-like, and fibronectin type III domains. SNED1 mediates cell adhesion predominantly through its RGD motif, enabling interactions with integrins including α5β1 and αvβ3. It plays a critical role in neural crest cell migration, craniofacial morphogenesis, and the metastatic dissemination of breast cancer cells. SNED1 is present in the ECM, forms microfibrils, is subject to glycosylation and phosphorylation, and interacts with other ECM proteins such as fibronectin. Its developmental and cancer-associated functions make it an emerging target for research into cell-matrix interactions and metastasis.
Blockade of SNED1-integrin interactions via competitive inhibition with RGD-based peptides (e.g., cyclic RGDfV inhibits binding of SNED1 to RGD-binding integrins such as α5β1 and αvβ3)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sushi, nidogen and EGF-like domains 1 (SNED1).